亚太地区部分国家老年人慢性病基本药物的价格和可及性

发布时间：2019-06-14 17:47

【摘要】：目的了解老年人慢性病基本药物在亚太地区6个国家的价格及可及性现状,为提高老年人慢性病基本药物的可及性提供依据和政策建议。方法采用二手资料分析法,从WHO/HAI调查数据中提取相关药品数据,根据通货膨胀/通货紧缩和购买力平价转化数据。结果 6个国家公立机构老年人慢性病基本药物通用药及原研药的可获得性分别为5.0%~80.0%、1.8%~15.4%,私立机构通用药及原研药可获得性分别为11.7%~54.5%、10.0%~65.6%;公立机构通用药及原研药的可负担性分别为0~1.2倍、0~5.0倍日薪,私立机构通用药及原研药的可负担性分别为0.3~2.0倍、1.2~7.0倍日薪;公立机构通用药及原研药的零售中位价格比(MPR)分别为0~32.88、0~79.13,私立机构通用药及原研药的的零售MPR分别为0.92~46.21、13.84~103.75。结论 6个国家老年人慢性病用药可获得性较低,药品价格高于国际水平,药品可负担性整体较差;6个国家的老年人慢性病基本药物的可及性有待提高。
[Abstract]:Objective to investigate the price and accessibility of essential drugs for chronic diseases in the elderly in six countries in the Asia-Pacific region, and to provide evidence and policy suggestions for improving the accessibility of essential drugs for chronic diseases in the elderly. Methods the data of related drugs were extracted from WHO/HAI survey data by second-hand data analysis, and the conversion data of inflation / deflation and purchasing power parity (PPP) were obtained according to the data of inflation / deflation and purchasing power parity (PPP). Results the availability of general drugs and original drugs for chronic diseases in the elderly in six national public institutions was 5.0% 80.0%, 1.8% 15.4%, 11.7% 54.5% and 10.0% 65.6%, respectively. the availability of general drugs and original drugs in private institutions was 11.7% 54.5% and 10.0%, respectively. the availability of general drugs and original drugs was 5.0% 80.0%, 1.8% 15.4%, 11.7% 54.5% and 10.0% 65.6% respectively. The affordability of general drugs and original drugs in public institutions was 0 卤1.2 times, 0 卤5.0 times daily salary, the affordability of general drugs and original drugs in private institutions was 0.3 times 2.0 times and 1.2 times 7.0 times, the median retail price ratio of general drugs and original drugs in public institutions was 0: 32.8, 0 / 79.13, and the retail MPR of general drugs and original drugs in private institutions was 0.92% 46.21 and 13.84% 103.75, respectively. Conclusion the availability of drugs for chronic diseases of the elderly in 6 countries is low, the price of drugs is higher than the international level, and the affordability of drugs is poor as a whole, and the accessibility of essential drugs for chronic diseases of the elderly needs to be improved in 6 countries.
【作者单位】：山东大学药学院;山东大学医药卫生管理学院国家卫生与计划生育委员会卫生经济与政策研究重点实验室(山东大学);
【基金】：山东大学基本科研业务费自助项目国际合作项目(2015GJ10)
【分类号】：R95

【相似文献】